EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Do first‐trimester screening algorithms for preeclampsia aligned to use of preventative therapies reduce the prevalence of pre‐term preeclampsia: A systematic review and meta‐analysis

Ailsa Borbolla Foster iD, Felicity Park, Jon Hyett

Prenatal Diagnosis · 2023

DOI: 10.1002/pd.6394 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Prenatal Diagnosis, 2023. Verfasst von Ailsa Borbolla Foster und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maternal and Fetal Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia. Hauptthemen laut MEDLINE: Pre-Eclampsia, Maternal Health Services. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Traditional obstetric practice relies upon history‐based assessment to screen for preeclampsia and guide preventative therapies but is hampered by low sensitivity, high false‐positive rates and low treatment rates. First‐trimester screening algorithms represent the most efficacious approach for risk prediction and could target early initiation of aspirin to well‐defined high‐risk populations. A large randomised controlled trial has demonstrated the clinical benefits of this approach, but widespread practice implementation has remained elusive.

Methods

We performed a systematic review and meta‐analysis summarising studies linking first‐trimester preeclampsia screening algorithms with the initiation of preventative therapy and examined their effect on pre‐term preeclampsia rates compared with standard maternity care. Odds ratios were calculated together with 95% confidence intervals.

Results

7 studies with a total of 377,790 participants were included. Within singleton populations, early initiation of aspirin in response to a high‐risk screening algorithm result reduced the prevalence of pre‐term preeclampsia by 39% compared with routine antenatal care (odds ratio 0.61; 95% CI: 0.52–0.70). There were significant reductions in the prevalence of preeclampsia at

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaMaternal Health ServicesPregnancyFemaleHumansPregnancy Trimester, FirstPrevalenceRisk AssessmentAspirinAlgorithmsRandomized Controlled Trials as Topic

Substanzen

Aspirin

Autor:innen und Institutionen

  • Department of Maternal and Fetal Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia.
  • Faculty of Medicine, University of Newcastle, Newcastle, New South Wales, Australia.
  • Ingham Institute for Applied Medical Research, Liverpool Hospital, Liverpool, New South Wales, Australia.
  • Deprtment of Obstetrics and Gynaecology, Faculty of Medicine, Western Sydney University, Newcastle, New South Wales, Australia.

ORCID-Profile: Ailsa Borbolla Foster

Zitieren

APA

Foster, A. B., Park, F., & Hyett, J. (2023). Do first‐trimester screening algorithms for preeclampsia aligned to use of preventative therapies reduce the prevalence of pre‐term preeclampsia: A systematic review and meta‐analysis. Prenatal Diagnosis. https://doi.org/10.1002/pd.6394

Vancouver

Foster AB, Park F, Hyett J. Do first‐trimester screening algorithms for preeclampsia aligned to use of preventative therapies reduce the prevalence of pre‐term preeclampsia: A systematic review and meta‐analysis. Prenatal Diagnosis. 2023. doi:10.1002/pd.6394

BibTeX
@article{Foster2023,
  author = {Foster, Ailsa Borbolla and Park, Felicity and Hyett, Jon},
  title = {Do first‐trimester screening algorithms for preeclampsia aligned to use of preventative therapies reduce the prevalence of pre‐term preeclampsia: A systematic review and meta‐analysis},
  journal = {Prenatal Diagnosis},
  year = {2023},
  doi = {10.1002/pd.6394}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche